C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion

Xia Lei1, G William Wong2

  • 1Department of Physiology and Center for Metabolism and Obesity Research, School of Medicine, The Johns Hopkins University, Baltimore, Maryland 21205 xia.lei@okstate.edu.

Insights

C1q/TNF-related protein 2 (CTRP2) is linked to obesity. CTRP2 deficiency boosts metabolism and fat breakdown, impacting body weight and lipid profiles in mice.

Area of Science:

  • Endocrinology
  • Metabolic research
  • Molecular biology

Background:

  • The C1q/TNF-related protein (CTRP) family regulates metabolism.
  • The specific role of CTRP2 in metabolic regulation is largely unknown.
  • CTRP2 expression correlates with BMI and obesity.

Purpose of the Study:

  • To elucidate the in vivo function of CTRP2 in metabolic regulation.
  • To investigate the impact of CTRP2 deficiency on adipose tissue and liver metabolism.

Main Methods:

  • Utilized a Ctrp2 knockout (KO) mouse model.
  • Analyzed metabolic rates, energy expenditure, and body composition.
  • Assessed lipolysis in adipocytes and adipose tissue.
  • Examined hepatic and plasma lipid profiles.
  • Performed liver metabolomic analysis.

Main Results:

  • Ctrp2-KO mice exhibited increased metabolic rates, energy expenditure, reduced body weight, and adiposity.
  • CTRP2 deficiency enhanced adipose tissue lipolysis via upregulation of lipolytic enzymes and PKA signaling.
  • CTRP2 suppressed triglyceride hydrolysis in adipocytes.
  • KO mice showed reduced liver size and hepatic triglyceride content but elevated plasma triglycerides.
  • Plasma and hepatic cholesterol levels were decreased in KO mice.
  • Loss of CTRP2 increased hepatic triglyceride secretion and impaired postprandial lipid clearance.

Conclusions:

  • CTRP2 plays a significant role in regulating lipid metabolism in adipose tissue and the liver.
  • CTRP2 deficiency leads to increased energy expenditure and altered lipid profiles.
  • Further research into CTRP2's role in obesity and metabolic disorders is warranted.

Related Concept Videos

Bacterial Translocation and Protein Secretion01:26

Bacterial Translocation and Protein Secretion

Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
547
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
527
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

3.8K
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
802
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
259